HopeStage
Back to all studies
CompletedNCT00095758

A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder

Medication studyAges 18–65United StatesDepression
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Beverly Hills and 27 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study clarity

Study information

Study start dateStarted: September 1, 2004
Recruitment status
Completed
Enrollment listed in the registry
1,151
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00095758
Official title
Show the full official title

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Beverly Hills · Burbank · National City

25 more locations
  • Orange
  • Pasadena
  • Denver
  • Farmington
  • Jacksonville
  • Orlando
  • Atlanta
  • Rockville
  • Albuquerque
  • Brooklyn
  • New York
  • Cincinnati
  • Toledo
  • Portland
  • Pittsburgh
  • Memphis
  • Dallas
  • Houston
  • Arlington
  • Herndon
  • Richmond
  • Bellevue
  • Seattle
  • Brown Deer
  • Middleton
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Antidepressant + Placebo and Antidepressant + Aripiprazole.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me